AMZN
Amazon.com, Inc.
AMZN's fundamentals are mixed: revenue grew 15%, but free cash flow turned negative. Its PE of 22x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect strong earnings growth.
XMAX
XMAX, Inc.
There isn't enough reported data to score XMAX yet.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
XMAX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Unavailable | |
| Strong |
XMAX's revenue and balance sheet are currently healthy, and its profitability is stable. There isn't enough data to rate its cash flow.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over XMAX in the historical PE scenario, which offers more potential upside but is not a forecast.
XMAX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 16x | $6.56 | — |
| Cheap | 17x | $6.78 | +3.4% |
| Fair | 21x | $8.62 | +31% |
| Expensive | 21x | $8.73 | +33% |
Historical ranges are pointers, not guarantees.
XMAX's PE is 16x, but its earnings don't support one, so it isn't a reliable read right now.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
XMAX Forward outlook
There aren't enough analyst estimates for XMAX to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN's earnings per share have climbed steadily: $12.37 over the past year, up 75% from the year before, and higher year over year for 14 quarters in a row. Its recent earnings include one-off gains.
XMAX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.41 | +$1.49 |
| Q1 2026 | -$0.14 | +$1.14 |
| Q4 2025 | -$0.17 | +$1.73 |
| Q3 2025 | -$0.42 | +$4.08 |
| Q2 2025 | -$1.08 | +$3.53 |
| Q1 2025 | -$1.28 | +$3.48 |
| Q4 2024 | -$1.90 | +$3.06 |
| Q3 2024 | -$4.50 | +$3.90 |
XMAX has returned to profit: it earned $0.41 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over XMAX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over XMAX on profitability, with a higher operating margin.
XMAX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.7M | +7.1% |
| Q1 2026 | $1.8M | -32% |
| Q4 2025 | $1.8M | -12% |
| Q3 2025 | $9.8M | +273% |
| Q2 2025 | $2.6M | -4.9% |
| Q1 2025 | $2.6M | +11% |
| Q4 2024 | $2M | -12% |
| Q3 2024 | $2.6M | +5.6% |
XMAX's revenue is growing: $3M last quarter, up 7.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -44% | -37 points |
| Q1 2026 | -30% | -23 points |
| Q4 2025 | -59% | -11 points |
| Q3 2025 | -5% | +87 points |
| Q2 2025 | -7.7% | +11 points |
| Q1 2025 | -7.3% | +55 points |
| Q4 2024 | -48% | +119 points |
| Q3 2024 | -92% | -50 points |
XMAX's operating margin was −44% last quarter, down 37 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
XMAX has the stronger cash trend. Its trailing FCF is up 57% versus its history, compared with AMZN at down 619%.
XMAX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$641.7K | -$319.1K |
| Q3 2025 | -$1.9M | -$1.5M |
| Q2 2025 | $92.5K | +$561.2K |
| Q1 2025 | -$322.6K | -$100.9K |
| Q4 2024 | -$263.4K | +$2.8M |
| Q1 2024 | -$221.7K | +$510.7K |
| Q4 2023 | -$3.1M | -$1.2M |
| Q1 2023 | -$732.4K | +$124.2K |
XMAX has burned cash in almost every quarter: −$3M over the past year, against −$1M the year before.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over XMAX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
XMAX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +36% | +16.2M shares |
| 1 year | +524% | +51.2M shares |
| 3 years | +4302% | +59.6M shares |
| 5 years | +5213% | +59.9M shares |
| Available history | +5210% | +59.9M shares |
XMAX has 61M diluted shares, up 524% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q3 2019 | $405,421 |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
XMAX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2019 | -1.0x | Net Cash |
| Q2 2019 | -4.5x | Net Cash |
XMAX has more cash than debt.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
XMAX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.5 | Neutral |
| Stochastic | 30.6 | Neutral |
XMAX's weekly RSI is 41 (neutral) and its Stochastic is 31 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
XMAX PE vs Consumer Cyclical Sector
| Metric | XMAX | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 11% below |
XMAX has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has stronger trend alignment. AMZN is above 5 of 5 weekly averages versus XMAX above 1 of 4.
XMAX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.64 | 14% below |
| 20 week MA | $8.29 | 21% below |
| 50 week MA | $7.48 | 12% below |
| 100 week MA | $4.85 | 35% above |
XMAX has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 35% above its 100-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over XMAX on returns for 2026, with the stronger performance.
XMAX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $3.77 | $3.77 | 0% |
| 2024 | $3.77 | $0.53 | -86% |
| 2025 | $0.53 | $6.00 | +1032% |
| 2026 YTD | $6.00 | $6.56 | +9.3% |
XMAX's yearly returns have swung widely, from +1032% in 2025 to −86% in 2024. It's up 9.3% so far in 2026.